AIM ImmunoTech Inc. (HEB) [Rocket]

In millions, except per share items	Jun-30-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q
Net income	-4.9	-4.4	-6.4	-4.9	-3.8	-5.8	-3.8	-5.9
Depreciation and amortization [+]		0.2	0.0	0.0	0.0	0.2	0.2	0.2
Depreciation		0.0	0.0	0.0	0.0	0.2	0.2	0.2
Amortization of intangible assets		0.2	0.0	0.0	0.0	0.0	0.0	0.0
Stock-based compensation		0.2	0.3	0.3	0.2	0.2	0.3	0.5
Change in working capital [+]		4.5	1.1	0.4	0.1	1.5	-0.1	0.2
Accounts receivable						0.0		0.0
Other current assets		0.3	-0.4	-0.1	0.0	1.6	0.0	0.0
Accounts payable		-0.6	0.2	0.3	0.2	-0.2	-0.1	0.3
Accrued expenses		-1.0	1.3	0.2	-0.1	0.1	0.0	-0.1
Other		5.7
Other operating activities		-6.5	0.0	1.8	0.7	-1.8	0.0	3.3
Cash from operations	-4.9	-6.1	-5.0	-2.3	-2.8	-5.7	-3.5	-1.7

Capital expenditures [+]	0.0	-0.1	0.0	0.0	0.0	0.0	0.0	0.0
Purchases of property and equipment		-0.1				0.0	0.0	0.0
Sales of property and equipment		3.6	0.3					0.2
Purchases of intangible assets		-0.1	0.0	0.0	0.0	-0.1	-0.1
Sales of short-term investments, net [+]		-0.1	0.0	7.8	-0.3	0.5	-0.3	-1.4
Purchases of short-term investments		-1.1	-0.4	-0.5	-0.7	-20.9	0.5	-0.9
Sales of short-term investments		1.0	0.4	8.3	0.4	21.4	-0.8	-0.4
Other cash from investing				-0.1
Cash from investing	0.0	3.4	0.3	7.7	-0.3	0.4	-0.4	-1.2

Issuance of common stock, net			0.0	0.1		0.1	0.0
Other cash from financing								-4.8
Cash from financing	0.0	0.0	0.0	0.1	0.0	0.1	0.0	-4.8

Free cash flow	-4.9	-6.2	-5.0	-2.3	-2.8	-5.8	-3.5	-1.7
Per share (diluted)	($0.10)	($0.13)	($0.10)	($0.05)	($0.06)	($0.12)	($0.07)	($0.04)